Omics

There may be a way to detect resistance to the emergency antibiotic colistin

Transcriptomic analysis may help predict the survival rate of Ebola patients

CRISPR is the new kid on the block, but do ZFNs and TALENs still have a place?

Vassilis Gorgoulis, Director of the Laboratory of Histology-Embryology, National and Kapodistrian University of Athens

Growing demand for multiple biomarker analysis gives diagnostics labs new challenges

MS identifies serum protein thresholds that could warn of disease before symptoms develop

Precision medicine’s focus on the genome may be blinding us to vital non-genomic tools

CAP, ASCP, and ASCO issue joint HER2 guidelines for gastroesophageal adenocarcinoma

With intellectual and metabolic differences, sequencing can aid diagnosis and treatment

A recent study says precision medicine really does make a difference in cancer care